Atos partners with Eupry to offer a Compliance Monitoring service for Covid-19 vaccine delivery

Paris, France – 21 December 2020

Atos has partnered with Eupry, a Danish startup specializing in automated storage compliance, to create a “Vaccine Logistics Checking as-a-Service” remedy. This will help community authorities and pharmaceutical and logistics companies to proficiently handle the offer chain of large-scale distribution of Covid-19 vaccines, as effectively as other vaccines in the long term, to ensure compliance with neighborhood polices, good manufacturing and distribution procedures and other elaborate specifications, this kind of as temperature.

Above the coming weeks, tens of millions of Covid-19 vaccine doses will be dispersed to around 100 countries concurrently. Logistically, the obstacle is two-fold. As Covid-19 vaccines have really serious temperature constraints that require to be rigorously monitored consistently throughout the logistics course of action, distribution desires to the two handle several transportation and storage phases in countless numbers of diverse points across each individual region, as effectively as protecting the environmental parameters within the regulation-compliant ranges, which in some cases exceed -70 ºC, depending on the vaccine.

Combining Eupry’s wireless knowledge loggers with Atos’ very long-standing knowledge in automation and monitoring together with its ability to effectively put into practice large jobs on a world scale, the joint remedy safeguards the logistics course of action conclusion-to-conclusion via a solitary platform. Eupry’s loggers keep track of temperatures from -200°C to 800°C, as effectively as differential force, humidity and carbon dioxide across the logistics chain (fridge, freezer, transportation and storage).

The joint remedy provides a thoroughly automatic assistance which optimizes assets and gets rid of the hazard of error and breach of compliance, such as:

  • Checking, alerting and protecting transportation & shipment compliance, tailor-made to customers’ desires
  • The remedy is IT-validated
  • Compliant in the direction of Food and drug administration PART11
  • Details loggers are shipped with ISO17025 calibrated (accredited) certificates
  • Constructed-in, conclusion-to-conclusion traceability with place monitoring
  • Scalability from a single up to countless numbers of models
  • Strong and proven stability solutions backed by Atos’ knowledge

Niels Thomsen, Team Vice President, World-wide Head of the Perception (IoT & AI) practice at Atos said: “The toll of Covid-19 on all aspects of our lives has been devastating and the vaccines provides us hope for a superior 2021. Organizing their distribution all around the earth in this kind of a brief time will be an particularly elaborate procedure and we are proud to add, at our level, by partnering with Eupry to supply a remedy that can simplify the function of people straight included.”

Christian Herschend Jacobsen, CEO at Eupry said: “It is remarkable how rapidly the everyday living science sector nowadays can develop hope for a brighter long term. From our encounter with UNICEF we know it is a major job to manufacture and distribute vaccines to billions of individuals earth-extensive and this is nevertheless in advance of us. It is vital that we do not waste or hurt vaccines thanks to improper storage conditions. We require to make the most of technological know-how to free of charge now overburdened health own from manual procedures such as high quality assurance. We – Eupry – commenced our journey back again in 2012 serving to Unicef and Clinton Health Obtain Initiative in their pursuit to supply superior high quality in vaccine distribution, and we managed to make a compliance assistance particularly for this variety of problem.”

To learn additional: https://atos.internet/en/solutions/atos-codex-connected-intelligence/atos-codex-iot

Down load the launch in pdf

***

About Atos

Atos is a world leader in digital transformation with a hundred and ten,000 staff and yearly income of € twelve billion. European quantity a single in cybersecurity, cloud and superior performance computing, the group provides tailor-made conclusion-to-conclusion solutions for all industries in seventy three countries. A pioneer in decarbonization providers and goods, Atos is dedicated to a secure and decarbonized digital for its clientele. Atos operates less than the models Atos and Atos|Syntel. Atos is a SE (Societas Europaea), stated on the CAC40 Paris stock index.

The purpose of Atos is to assistance style and design the long term of the information room. Its knowledge and providers assist the development of know-how, schooling and analysis in a multicultural strategy and add to the development of scientific and technological excellence. Throughout the earth, the group permits its customers and staff, and customers of societies at large to reside, function and develop sustainably, in a harmless and secure information room.

About Eupry

Eupry is a Danish tech startup with a distinctive global profile within the IOT sector. Eupry has proven to lower compliance function by 70% in pharma companies, hospitals, laboratories, and GDP logistics, due to the fact of a comprehensive aim on compliance optimization and thermal calibration automation. Eupry runs a thoroughly automatic ISO17025 accredited laboratory and has produced a extensive range of solutions such as many wireless sensors, application apps and calibration solutions. In Eupry we provide clientele with a entire package deal of compliance providers to consider care of storage this kind of as thermal mapping, qualifications, automatic calibrations, temperature and humidity monitoring. Eupry is driven by a solid founding group, focused team, and funded by the Danish Progress Foundation.

Eupry operates to free of charge dazzling minded individuals from manual high quality assurance procedures by working with our unrestricted passion for technological know-how to make the world’s easiest compliance encounter – for storing sensitive assets in the everyday living science and health sector.

Press speak to: Marion Delmas | [email protected] | +33 six 37 63 91 ninety nine